Medically reviewed by Marisa Garshick, MD Laser hair removal is a safe and effective option for treating hidradenitis ...

Medically reviewed by Brendan Camp, MD Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that causes ...

The 2024 American Academy of Dermatology conference was held in San Diego, California March 8 to 11.

Armpit pain can be caused by many issues, from muscle strains to swollen lymph nodes. Here are possible causes of underarm ...

Kymera Therapeutics (NASDAQ:KYMR – Get Free Report)‘s stock had its “outperform” rating restated by analysts at Leerink ...

Franklin Resources Inc. grew its stake in Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 35.1% in the third quarter ...

Anifrolumab is under clinical development by AstraZeneca and currently in Phase II for Vitiligo. According to GlobalData, Phase II drugs for Vitiligo have a 42% phase transition success rate (PTSR) ...

Inmagene Biopharmaceuticals is a clinical stage company focused on developing IMG-007, a non-depleting anti-OX40 monoclonal ...

Ikena Oncology (IKNA) and Inmagene Biopharmaceuticals have entered into a definitive merger agreement. In connection with the merger, Ikena has ...

Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis ...

In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug, but patients with schizophrenia gained the first new treatment with a ...

FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.